Cytotoxicity of alkaline serine protease (ASPNJ) on Jurkat cells and its correlation with changes in the expression of membrane-associated proteins.


Journal

Journal of biochemical and molecular toxicology
ISSN: 1099-0461
Titre abrégé: J Biochem Mol Toxicol
Pays: United States
ID NLM: 9717231

Informations de publication

Date de publication:
Nov 2023
Historique:
revised: 15 05 2023
received: 31 08 2022
accepted: 04 07 2023
medline: 10 11 2023
pubmed: 13 7 2023
entrez: 13 7 2023
Statut: ppublish

Résumé

We aim to study the inhibitory effect of alkaline serine protease (ASPNJ) on lymphocytic leukemia Jurkat cells and its related mechanism through examining the expression of membrane proteins or membrane-associated proteins. MTT assay and trypan blue staining were used to detect the inhibitory effect of ASPNJ on the proliferation and growth of Jurkat cells. Wright-Giemsa staining was used to observe the effect of ASPNJ on the morphology of Jurkat cells. The effect of ASPNJ on Jurkat cell apoptosis was detected by flow cytometry. Two-dimensional electrophoresis-mass spectrometry (2-DE-MS) was used to detect and identify the differentially expressed proteins of Jurkat cells treated with ASPNJ (4 μg/mL, 3 h), of which three were selected and verified by Western blot. ASPNJ significantly inhibited the proliferation of leukemia cells (Raji, U937, and Jurkat), caused obvious morphological changes, and induced apoptosis of Jurkat cells. ASPNJ also increased the sensitivity of Jurkat cells to vincristine (VCR). Seven differentially expressed proteins were obtained through 2DE-MS, of which Peroxiredoxin-6 (PRDX6), Calcium-binding protein (CHP1), and 40S ribosomal protein SA (RPSA) were validated. ASPNJ can cause significant toxic effects on Jurkat cells and enhance the effects of VCR. The mechanism of action of ASPNJ on Jurkat cells may be related to differentially expressed proteins such as PRDX6. This study provides a new experimental basis and direction for antileukemia research.

Identifiants

pubmed: 37439684
doi: 10.1002/jbt.23456
doi:

Substances chimiques

Serine Proteases EC 3.4.-
Serine 452VLY9402
Membrane Proteins 0
Vincristine 5J49Q6B70F
Serine Endopeptidases EC 3.4.21.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e23456

Subventions

Organisme : Jilin University

Informations de copyright

© 2023 Wiley Periodicals LLC.

Références

J. H. C. Chang, M. M. Poppe, C. H. Hua, K. J. Marcus, N. Esiashvili, Pediatr. Blood. Cancer 2021, 68(Suppl 2), e28371. https://doi.org/10.1002/pbc.28371
S. P. Hunger, E. A. Raetz, Blood 2020, 136(16), 1803. https://doi.org/10.1182/blood.2019004043
V. Conter, M. Aricò, G. Basso, A. Biondi, E. Barisone, C. Messina, R. Parasole, G. De Rossi, F. Locatelli, A. Pession, N. Santoro, C. Micalizzi, M. Citterio, C. Rizzari, D. Silvestri, R. Rondelli, L. L. Nigro, O. Ziino, A. M. Testi, G. Masera, M. G. Valsecchi, Associazione Italiana di Ematologia ed Oncologia Pediatrica, Leukemia 2010, 24(2), 255. https://doi.org/10.1038/leu.2009.250
S. Mengxuan, Z. Fen, J. Runming, Front. Pediatr. 2022, 10, 923419. https://doi.org/10.3389/fped.2022.923419
M. K. Verma, K. K. Pulicherla, Amino Acids 2016, 48(4), 941. https://doi.org/10.1007/s00726-015-2162-3
H. Chen, S. Takahashi, M. Imamura, E. Okutani, Z. Zhang, K. Chayama, B. Chen, Chin. Med. J. 2007, 120(10), 898.
X. Ge, Q. Bo, X. Hong, J. Cui, X. Jiang, M. Hong, J. Liu, Leuk. Res. 2013, 37(12), 1697. https://doi.org/10.1016/j.leukres.2013.09.017
Q. Bo, X. Ge, X. Hong, J. Cui, X. Jiang, J. Liu, M. Hong, Chin. J. Biochem. Pharm. 2012, 33(6), 736.
Z. Deng, S. Wang, Q. Li, X. Ji, L. Zhang, M. Hong, Bioresour. Technol. 2010, 01(6), 1954. https://doi.org/10.1016/j.biortech.2009.10.014
S. H. Wang, Q. Li, Z. H. Deng, X. Ji, X. Jiang, X. Ge, Q. Q. Bo, J. Y. Cui, L. Z. Zhang, J. K. Liu, M. Hong, Neurosci. Lett. 2011, 489(1), 16. https://doi.org/10.1016/j.neulet.2010.11.057
X. Zhan, Y. Huang, Y. Long, J. Visualized Exp. 2018, (134), 56739. https://doi.org/10.3791/56739
D. F. Hochstrasser, M. G. Harrington, A. C. Hochstrasser, M. J. Miller, C. R. Merril, Anal. Biochem. 1988, 173(2), 424. https://doi.org/10.1016/0003-2697(88)90209-6
D. H. Zhou, F. R. Zhao, S. Y. Huang, M. J. Xu, H. Q. Song, C. Su, X. Q. Zhu, Parasit. Vectors. 2013, 6, 96. https://doi.org/10.1186/1756-3305-6-96
J. N. Ho, S. B. Lee, S. S. Lee, S. H. Yoon, G. Y. Kang, S. G. Hwang, H. D. Um, Mol. Cancer Ther. 2010, 9(4), 825. https://doi.org/10.1158/1535-7163.MCT-09-0904
J. H. Pak, W. H. Choi, H. M. Lee, W. D. Joo, J. H. Kim, Y. T. Kim, Y. M. Kim, J. H. Nam, Cancer Invest. 2011, 29(1), 21. https://doi.org/10.3109/07357907.2010.535056
X. Z. Chang, D. Q. Li, Y. F. Hou, J. Wu, J. S. Lu, G. H. Di, W. Jin, Z. L. Ou, Z. Z. Shen, Z. M. Shao, J. Breast Cancer 2007, 9(6), R76. https://doi.org/10.1186/bcr1789
V. L. Kinnula, S. Lehtonen, R. Sormunen, R. Kaarteenaho-Wiik, S. W. Kang, S. G. Rhee, Y. Soini, J. Pathol. 2002, 196(3), 316. https://doi.org/10.1002/path.1042
S. T. Lehtonen, A. M. Svensk, Y. Soini, P. Pääkkö, P. Hirvikoski, S. W. Kang, M. Säily, V. L. Kinnula, Int. J. Cancer 2004, 111(4), 514. https://doi.org/10.1002/ijc.20294
H. M. Yun, K. R. Park, H. P. Lee, D. H. Lee, M. Jo, D. H. Shin, D. Y. Yoon, S. B. Han, J. T. Hong, Free Radic. Biol. Med. 2014, 69, 367. https://doi.org/10.1016/j.freeradbiomed.2014.02.001
Z. Fang, T. Liu, X. Liu, Y. Lu, Y. Sun, R. Xiao, R. Fan, L. Liu, Transl. Cancer Res. 2019, 8(5), 1772. https://doi.org/10.21037/tcr.2019.08.36
J. J. Provost, M. A. Wallert, Chem. Biol. Drug Des. 2013, 81(1), 85. https://doi.org/10.1111/cbdd.12035
B. S. Kim, K. Lee, H. J. Jung, D. Bhattarai, H. J. Kwon, Biochem. Biophys. Res. Commun. 2015, 458(1), 14. https://doi.org/10.1016/j.bbrc.2015.01.031
A. A. Malygin, E. S. Babaylova, V. B. Loktev, G. G. Karpova, Biochimie 2011, 93(3), 612. https://doi.org/10.1016/j.biochi.2010.12.005
G. Fontanini, S. Vignati, S. Chiné, M. Lucchi, A. Mussi, C. A. Angeletti, S. Ménard, V. Castronovo, G. Bevilacqua, Clin. Cancer Res. 1997, 3(2), 227.
D. G. Song, Y. S. Kim, B. C. Jung, K. J. Rhee, C. H. Pan, Appl. Biochem. Biotechnol. 2013, 171(7), 1630. https://doi.org/10.1007/s12010-013-0443-4

Auteurs

Jianyi Zhang (J)

Biochemistry Department, College of Basic Medical Sciences, Jilin University, Changchun, Jilin, China.
Functional Science Experiment Center, College of Basic Medical Sciences, Jilin University, Changchun, Jilin, China.

Chunhua Li (C)

Biochemistry Department, College of Basic Medical Sciences, Jilin University, Changchun, Jilin, China.

Kai Ren (K)

Blood Transfusion Department, The Second Hospital of Jilin University, Changchun, Jilin, China.

Min Hong (M)

Biochemistry Department, College of Basic Medical Sciences, Jilin University, Changchun, Jilin, China.

Jiayue Cui (J)

Department of Histology and Embryology, College of Basic Medical Sciences, Jilin University, Changchun, Jilin, China.

Jiankai Liu (J)

Biochemistry Department, College of Basic Medical Sciences, Jilin University, Changchun, Jilin, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH